Literature DB >> 33620575

Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.

Tomonori Sasahira1, Miyako Kurihara-Shimomura2,3, Hiroyuki Shimomura2,3, Anja Katrin Bosserhoff4, Tadaaki Kirita3.   

Abstract

PURPOSE: Transport and Golgi organization protein 1 (TANGO) promotes angiogenesis and lymphangiogenesis in oral squamous cell carcinoma (OSCC). To elucidate the underlying mechanisms, this study aims to identify and characterize elements downstream of TANGO that mediate its involvement in OSCC.
METHODS: In this study, microarray analysis compared gene expression between control and TANGO-repressed HSC3 cells. Protein expression in 213 OSCC tissue samples was analyzed immunohistochemically.
RESULTS: TANGO repression decreased or increased expression of Mucin 20 (MUC20) and small proline-rich protein 1B (SPRR1B), respectively. MUC20 increased the growth and invasiveness of OSCC cells via altered matrix metalloproteinase (MMP)-2 and E-cadherin expression and c-met phosphorylation. MUC20 induced angiogenesis and lymphangiogenesis by activating vascular endothelial growth factors A and C. In well-differentiated OSCC, SPRR1B expression was high (P = 0.0091) and correlated with keratinization markers and promoted proliferation by inducing mitogen-activated protein kinase p38 phosphorylation. MUC20 expression correlated significantly with clinical stage (P = 0.0024), lymph node metastasis (P = 0.0036), and number of blood and lymph vessels (P < 0.0001). MUC20-expressing cases had a significantly worse prognosis than non-expressing cases (P < 0.0001).
CONCLUSION: MUC20 and SPRR1B located downstream of TANGO may be useful molecular markers for OSCC.

Entities:  

Keywords:  MUC20; Oral cancer; SPRR1B; TANGO

Year:  2021        PMID: 33620575     DOI: 10.1007/s00432-021-03568-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  TANGO is a tumor suppressor of malignant melanoma.

Authors:  Stephanie Arndt; Anja K Bosserhoff
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

2.  Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions.

Authors:  W Fujimoto; G Nakanishi; J Arata; A M Jetten
Journal:  J Invest Dermatol       Date:  1997-02       Impact factor: 8.551

3.  MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.

Authors:  Chi-Hau Chen; Ming-Kwang Shyu; Shu-Wei Wang; Chih-Hsing Chou; Miao-Juei Huang; Tzu-Chi Lin; Syue-Ting Chen; Ho-Hsiung Lin; Min-Chuan Huang
Journal:  Gynecol Oncol       Date:  2015-11-23       Impact factor: 5.482

4.  MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Authors:  Toshio Higuchi; Takuya Orita; Ken Katsuya; Yoshiki Yamasaki; Kiyotaka Akiyama; Huiping Li; Tadashi Yamamoto; Yutaka Saito; Motonao Nakamura
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney.

Authors:  Toshio Higuchi; Takuya Orita; Setsuko Nakanishi; Ken Katsuya; Hirotaka Watanabe; Yoshiki Yamasaki; Iwao Waga; Toyomichi Nanayama; Yoshihisa Yamamoto; William Munger; Hong-Wei Sun; Ronald J Falk; J Charles Jennette; David A Alcorta; Huiping Li; Tadashi Yamamoto; Yutaka Saito; Motonao Nakamura
Journal:  J Biol Chem       Date:  2003-10-17       Impact factor: 5.157

6.  Reduced expression of TANGO in colon and hepatocellular carcinomas.

Authors:  Stephanie Arndt; Anja K Bosserhoff
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

7.  MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.

Authors:  Chi-Hau Chen; Shu-Wei Wang; Chih-Wei Chen; Miao-Ruei Huang; Ji-Shiang Hung; Hsiu-Chin Huang; Ho-Hsiung Lin; Ruey-Jien Chen; Ming-Kwang Shyu; Min-Chuan Huang
Journal:  Gynecol Oncol       Date:  2012-12-19       Impact factor: 5.482

8.  Calcipotriol (MC 903), a synthetic derivative of vitamin D3 stimulates differentiation of squamous carcinoma cell line in the raft culture.

Authors:  K H Cho; Y S Son; D Y Lee; E K Chung; K C Hur; S I Hong; E Fuchs
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

9.  MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer.

Authors:  Heli Gao; Xuejing Cong; Jianfeng Zhou; Mei Guan
Journal:  Cancer Cell Int       Date:  2017-08-29       Impact factor: 5.722

10.  Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.

Authors:  Syue-Ting Chen; Ting-Chun Kuo; Ying-Yu Liao; Mei-Chun Lin; Yu-Wen Tien; Min-Chuan Huang
Journal:  Oncogene       Date:  2018-07-11       Impact factor: 9.867

View more
  1 in total

Review 1.  Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Yudai Shimojjukoku; Kaori Shima; Tadaaki Kirita
Journal:  J Pers Med       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.